Development of a Modular Tissue Phantom for Evaluating Vascular Access Devices

Central vascular access (CVA) may be critical for trauma care and stabilizing the casualty. However, it requires skilled personnel, often unavailable during remote medical situations and combat casualty care scenarios. Automated CVA medical devices have the potential to make life-saving therapeutics...

Full description

Saved in:
Bibliographic Details
Published inBioengineering (Basel) Vol. 9; no. 7; p. 319
Main Authors Boice, Emily N, Berard, David, Gonzalez, Jose M, Hernandez Torres, Sofia I, Knowlton, Zechariah J, Avital, Guy, Snider, Eric J
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 15.07.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Central vascular access (CVA) may be critical for trauma care and stabilizing the casualty. However, it requires skilled personnel, often unavailable during remote medical situations and combat casualty care scenarios. Automated CVA medical devices have the potential to make life-saving therapeutics available in these resource-limited scenarios, but they must be properly designed. Unfortunately, currently available tissue phantoms are inadequate for this use, resulting in delayed product development. Here, we present a tissue phantom that is modular in design, allowing for adjustable flow rate, circulating fluid pressure, vessel diameter, and vessel positions. The phantom consists of a gelatin cast using a 3D-printed mold with inserts representing vessels and bone locations. These removable inserts allow for tubing insertion which can mimic normal and hypovolemic flow, as well as pressure and vessel diameters. Trauma to the vessel wall is assessed using quantification of leak rates from the tubing after removal from the model. Lastly, the phantom can be adjusted to swine or human anatomy, including modeling the entire neurovascular bundle. Overall, this model can better recreate severe hypovolemic trauma cases and subject variability than commercial CVA trainers and may potentially accelerate automated CVA device development.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
SC0014664
US Dept. of Defense (DOD)
USDOE Office of Science (SC)
ISSN:2306-5354
2306-5354
DOI:10.3390/bioengineering9070319